Literature DB >> 9585716

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode.

P E Keck1, S L McElroy, S M Strakowski, S A West, K W Sax, J M Hawkins, M L Bourne, P Haggard.   

Abstract

OBJECTIVE: The authors studied the 12-month course of illness following hospitalization for a manic or mixed episode of bipolar disorder to identify potential outcome predictors.
METHOD: They recruited 134 patients with DSM-III-R bipolar disorder who were consecutively admitted for the treatment of a manic or mixed episode. Diagnostic, symptomatic, and functional evaluations were obtained at the index hospitalization. Patients were reevaluated at 2, 6, and 12 months after discharge to assess syndromic, symptomatic, and functional outcome. Factors associated with outcome were identified by using multivariate analyses.
RESULTS: During the 12-month follow-up period, there were no significant differences in outcome between patients with manic compared with mixed bipolar disorder. Although syndromic recovery occurred in 48% of the overall group, symptomatic recovery occurred in only 26% and functional recovery in only 24%. Predictors of syndromic recovery included shorter duration of illness and full treatment compliance. Medication treatment compliance was inversely associated with the presence of comorbid substance use disorders. Symptomatic and functional recovery occurred more rapidly and in a greater percentage of patients from higher social classes.
CONCLUSIONS: A minority of patients with bipolar disorder achieved a favorable outcome in the year following hospitalization for a manic or mixed episode. Shorter duration of illness, higher social class, and treatment compliance were associated with higher rates of recovery and more rapid recovery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585716     DOI: 10.1176/ajp.155.5.646

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  84 in total

Review 1.  Functional impairment and cognition in bipolar disorder.

Authors:  C A Zarate; M Tohen; M Land; S Cavanagh
Journal:  Psychiatr Q       Date:  2000

Review 2.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  The management of acute mania.

Authors:  Paul E Keck
Journal:  BMJ       Date:  2003-11-01

4.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

Review 5.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 6.  [Mixed affective disorders].

Authors:  A Marneros
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

7.  Point-counterpoint: the importance of "open access" to psychotropics for our patients.

Authors:  Alan D Schmetzer; John J Wernert
Journal:  Psychiatr Q       Date:  2006

Review 8.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

9.  Longitudinal trajectories of mood symptoms and global functioning in youth at high risk for bipolar disorder.

Authors:  Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; Manpreet K Singh; David J Miklowitz
Journal:  J Affect Disord       Date:  2020-08-13       Impact factor: 4.839

10.  Effect of candidate gene polymorphisms on the course of attention deficit hyperactivity disorder.

Authors:  Joseph Biederman; Carter R Petty; Kristina S Ten Haagen; Jacqueline Small; Alysa E Doyle; Thomas Spencer; Eric Mick; Michael C Monuteaux; Jordan W Smoller; Stephen V Faraone
Journal:  Psychiatry Res       Date:  2009-11-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.